Physician profile
Yanyan E Shi
NPI 1912138470
$1,524.98
in general payments reported to CMS, 2019-2025
15 companies · $112 in 2025
The $112 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $530 · 2020: $80.81 · 2021: $268 · 2022: $245 · 2023: $144 · 2024: $146 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $289.73 | 2023-2024 | Sotyktu |
| Pfizer INC. | $199.14 | 2019-2021 | |
| Foundation Medicine, INC. | $148.30 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $147.40 | 2020-2022 | |
| Biogen, INC. | $124.99 | 2019 | |
| Abbvie INC. | $124.97 | 2022 | |
| Incyte Corporation | $111.52 | 2025 | Opzelura |
| Alexion Pharmaceuticals, INC. | $102.38 | 2019 | |
| Glaxosmithkline, LLC. | $74.81 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $74.10 | 2019-2021 | |
| Tris Pharma INC | $47.42 | 2019-2021 | |
| Sobi, INC | $34.87 | 2020 | |
| Kaleo, INC. | $19.14 | 2019 | |
| Genentech USA, INC. | $13.77 | 2020 | |
| Intrafusion Gp, LLC | $12.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yanyan Shi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.